19 Breast Cancer

Breast Cancer 451

2. Bartelink H, Horiot JC, Poortmans PM, et al. Recurrence rates after treament of breast cancer with standard radiotherapy with nor without additional radiation. N Engl J Med 2001; 345 (19) : 1378-87. 3. Borger JH, Kemperman H, Smitt HS, et al. Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys 1994; 30 (5) : 1073-81. 4. Calitchi E, Otmezguine Y, Feuilhade F, et al. External irradiation prior to conservative surgery for breast cancer treatment . Int J Radiat Oncol Biol Phys 1991; 21 : 325-29. 5. Clarke DH, Lé MG, Sarrazin D, et al. Analysis of local regional relapses in patients with early breast cancers treated by excision and radiotherapy. Experience of the Institute Gustave Roussy. Int J Radiat Oncol Biol Phys 1985; 11 : 137-45. 6. Collette L, Fourquet A, Horiot JC, et al. Impact of a boost of 16 Gy on local control in patients with early breast cancer: the EORTC “Boost versus no boost” trial. Radioth Oncol 2000; 56 (Suppl 1) : 46 (abstract 168). 7. De la Rochefordière A, Abner AL, Silver B, et al. Are cosmetic results following conservative surgery and radiation therapy for early breast cancer dependent on technique? Int J Radiat Oncol Biol Phys 1992; 23 (5): 925-317. 8. Deore SM, Sarin R, Dingshaw K, Shrivastava SK. Influence of dose rate and dose per fraction on clinical outcome of breast cancer tyreated by external beam irradiation plus iridium-192 implants. Analysis of 289 cases. Int J Radiat Oncol Biol Phys 1993; 26 : 601-6. 9. Fentiman Is, Poole C, Tong D, et al. Inadequacy of iridium implant as a sole radiation treatment for operable breast cancer. Eur J Cancer 1996; 32 : 608-11, 10. Fourquet A, Campana F, Mosseri V, et al. Iridium 192 versus cobalt 60 boost in 3-7 cm breast cancer treated by irradiation alone: final results of a randomized trial. Rad Onc 1995; 34 : 114- 20. 11. Fowble B, Solin LJ, Martz KL, et al. The influence of the type of boost (electrons vs. implant) on local control and cosmesis in patients with stages I and II breast cancer undergoing conservative surgery and radiation. Int J Radiat Oncol Biol Phys 1986; 12 : 150 (abstract). 12. Fowler JF, Van Limbergen E. Biological effect of pulsed dose rate brachytherapy with stepping sources, if short half-times of repair are present in tissues. Int J Radiat Oncol Biol Phys 1997; 37 : 877-83. 13. Fritz P, Berns C, Anton HW, et al. PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy. Radiother Oncol 1997; 45 (1) : 23-32. 14. Guedea F, Biete A, Craven-Bartle J, et al. External and interstitial radiation therapy of mocally advanced carcinoma of the breast. Acta Oncol 1992; 31 : 303-6. 15. Gump FE. Multicentricity in early breast cancer. Semin Surg Oncol 2001; 177 : 330-37. 16. Haagensen CD. Diseases of the Breast. Philadelphia WB Saunders 1971; Ed 2 : 13. 17. Habibollahi F, Mayles HM, Mayles WP, et al. Assessment of skin dose and its relation to cosmesis in the conservative treatment of early breast cancer. Int J Radiat Oncol Biol Phys 1988; 14 : 291-6. 18. Hammer J, Seewald DH, Track C, et al. Breast cancer: primary treatment with external-beam radiation therapy and high-dose-rate iridium implantation. Radiology 1994; 193 (2) : 573-7. 19. Hammer J, Track C, Seewald DH, et al. Breast Cancer: External beam radiotherapy and interstitial iridium implantation - 10-year clinical results. EJC 1998; 34 (suppl 1 ): 32 (abstract). 20. Hammer J. What are the minimal requirements for boost target localisation? In J. Hammer and E. Van Limbergen: Breast cancer to boost or not to Boost and how to do it. Consensus meeting on Breast Cancer GEC-ESTRO annual Meeting Stresa 2001. 21. Harrington KJ, Harrison M, Bayle P, et al. Surgical clips in planning the electron boost in breast cancer: a qualitative and quantitative evaluation. Int J Radiat Oncol Biol Phys 1996; 34 : 579-84. 22. Hennequin C, Durdux C, Espié M, et al. High Dose Rate brachytherapy for early breast cancer: an ambulatory technique. Rad Onc 1994; 31 (supl 33) . 23. Holland R, Veling SH, Mravunac M, Hendriks J. Histologic multifocality of Tis, T1 T2 breast carcinomas. Implications for clinical trials of breast conserving therapy. Cancer 1985; 56 : 979-90.